688566 Jiangsu Jibeier Pharmaceutical Co., Ltd.
- 24.78
- +0.60+2.48%
Jiangsu Jibeier Pharmaceutical Co., Ltd. News
Gibbel: Guojin Securities Co., Ltd.\'s inspection opinion on the foreign investment and related transactions of Jiangsu Gibel Pharmaceutical Co., Ltd.
Gibbel: Announcement of Resolutions of the 11th Meeting of the Fourth Board of Supervisors of Gibbel
Announcement of Resolutions of the 11th Meeting of the Fourth Board of Supervisors of Gibbel
Independent opinions of independent directors of Jiangsu Jebel Pharmaceutical Co., Ltd. on matters related to the 12th meeting of the fourth board of directors
Gibbel: Gibel\'s Voluntary Disclosure Notice on Obtaining Patents for Inventions
Gibel\'s Voluntary Disclosure Notice on Obtaining Invention Patents
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form (2024 Semi-Annual Results Briefing)
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form September 18, 2024
Gibbel: Gibel\'s announcement on holding the 2024 semi-annual results briefing
Gibel\'s announcement on holding the 2024 semi-annual results briefing
Jiangsu Gibel Pharmaceutical Co., Ltd. Investor Relations Activity Record Form August 30, 2024
Special report on the storage and actual use of Gibbel\'s 2024 semi-annual funds raised
Independent opinions of independent directors of Jiangsu Jebel Pharmaceutical Co., Ltd. on matters related to the 10th meeting of the fourth board of directors
Gibel\'s announcement on the use of raised funds to replace pre-invested self-financing in fund-raising projects
Announcement of Resolutions of the 10th Meeting of the Fourth Board of Supervisors of Gibbel
Announcement of Resolutions of the 10th Meeting of the Fourth Board of Directors of Gibel
Guojin Securities Co., Ltd.\'s inspection opinion on the adjustment of the implementation plan of some fund-raising investment projects of Jiangsu Gibel Pharmaceutical Co., Ltd.
Guojin Securities Co., Ltd.\'s 2024 semi-annual continuous supervision and follow-up report on Jiangsu Gibel Pharmaceutical Co., Ltd.
Gibbel 2024 Semi-Annual Evaluation Report on the “Improve Quality, Increase Efficiency, and Focus on Return” Action Plan
Opinions of Guojin Securities Co., Ltd. on the inspection opinion of Jiangsu Gibel Pharmaceutical Co., Ltd. on the use of raised funds in exchange for pre-investment of self-raised funds
Analysis
Price Target
No Data
No Data